Search company, investor...


Unattributed - II | Alive

Total Raised


Last Raised

$1.63M | 8 yrs ago

About Liquid Genomics

Liquid Genomics monitors patient therapy via blood-based molecular testing. Blood based testing is used to detect and quantify cancer gene mutations with high sensitivity using Digital PCR and or Allele Specific Blocker PCR for blood or tissue.

Headquarters Location

1725 Del Amo Blvd

Torrance, California, 90501,

United States




Expert Collections containing Liquid Genomics

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Liquid Genomics is included in 2 Expert Collections, including Digital Health.


Digital Health

10,804 items

The digital health collection includes vendors developing software, platforms, sensor & robotic hardware, health data infrastructure, and tech-enabled services in healthcare. The list excludes pureplay pharma/biopharma, sequencing instruments, gene editing, and assistive tech.


Oncology Tech

457 items

This collection includes companies applying technology to cancer care, diagnosis, and treatment. Examples include vendors offering cancer detection and diagnosis, oncology clinical decision support, real-world data, and AI oncology drug discovery.

Liquid Genomics Patents

Liquid Genomics has filed 2 patents.

The 3 most popular patent topics include:

  • dna
  • dna sequencing
  • genetics
patents chart

Application Date

Grant Date


Related Topics



Clusters of differentiation, Oncology, Psychiatric diagnosis, Antineoplastic drugs, Immune system


Application Date


Grant Date


Related Topics

Clusters of differentiation, Oncology, Psychiatric diagnosis, Antineoplastic drugs, Immune system



Liquid Genomics Frequently Asked Questions (FAQ)

  • Where is Liquid Genomics's headquarters?

    Liquid Genomics's headquarters is located at 1725 Del Amo Blvd, Torrance.

  • What is Liquid Genomics's latest funding round?

    Liquid Genomics's latest funding round is Unattributed - II.

  • How much did Liquid Genomics raise?

    Liquid Genomics raised a total of $4.87M.

  • Who are Liquid Genomics's competitors?

    Competitors of Liquid Genomics include Freenome and 4 more.


Compare Liquid Genomics to Competitors

OncoTAB Logo

OncoTAB is a biotechnology company focused on improving the quality of cancer care. The company's main offering is a non-invasive blood test that aids in the detection of breast cancer in women with dense breast tissue. OncoTAB primarily serves the healthcare industry. It is based in Charlotte, North Carolina.

Owlstone Medical Logo
Owlstone Medical

Owlstone Medical is a diagnostics company developing a breathalyzer for disease detection. It offers a breath biopsy platform to enable early detection across multiple cancers and other related conditions. The company was founded in 2004 and is based in Cambridge, U.K.

20/20 GeneSystems Logo
20/20 GeneSystems

20/20 GeneSystems is a company focused on modernizing clinical lab testing, primarily in the healthcare and biotechnology sectors. The company offers diagnostic tests that aid in the fight against cancer and COVID-19, utilizing machine learning and real-world data to provide comprehensive testing services. Their main offerings include a blood test that combines the results of multiple cancer biomarker tests to calculate a probability score for different types of cancers, and a range of COVID-19 testing services. It is based in Rockville, Maryland.

Freenome Logo

Freenome serves as a biotechnology company focused on early cancer detection through advanced diagnostic tools. The company develops blood tests that identify early signs of cancer by analyzing biomarkers from tumor and non-tumor sources using a multiomics platform. These tests are designed to be non-invasive and accessible, aiming to detect various types of cancer at its most treatable stages. It was founded in 2014 and is based in South San Francisco, California.


Accuragen is a company focused on the development of cancer diagnostics technology in the healthcare sector. The company's main service is the development of liquid biopsy technology, which is a non-invasive alternative to tissue biopsy, used for DNA and RNA sequencing to determine a patient's optimal treatment plan. Accuragen primarily sells to the healthcare industry, specifically in the field of cancer treatment. It is based in Menlo Park, California.

Blueberry Diagnostics Logo
Blueberry Diagnostics

Blueberry Diagnostics is a biotechnology company. It offers AI testing solutions to healthcare professionals to detect cancer in its early stages. The company was founded in 2019 and is based in Wilmington, Delaware.


CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.